{"id":472,"date":"2021-12-31T10:23:07","date_gmt":"2021-12-31T02:23:07","guid":{"rendered":"http:\/\/nugene.com.cn\/en\/?p=472"},"modified":"2021-12-31T10:23:08","modified_gmt":"2021-12-31T02:23:08","slug":"chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million","status":"publish","type":"post","link":"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/","title":{"rendered":"Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million."},"content":{"rendered":"\n<p>People familiar with the matter said that relevant consultations are still in progress, and details such as the scale and timing of fundraising may be adjusted. A spokesperson for the SoftBank Vision Fund declined to comment, and representatives of Abogen and Mirae Asset did not immediately respond to requests for comment or were unable to comment immediately.<\/p>\n\n\n\n<p>Abogen Biosciences  announced in August that it had raised more than US$700 million in Series C financing led by Temasek Holdings and Invesco Developing Markets Fund to support the clinical development of its potential new crown vaccine and expand its product line of other vaccines and therapeutic drugs. According to a press release from Qiming Ventures, the Suzhou-based company received US$600 million in Series B financing in April.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>People familiar with the matter said that relevant consultations are still in progress, and details such as the scale and timing of fundraising may be adjusted. A spokesperson for the SoftBank Vision Fund declined to comment, and representatives of Abogen and Mirae Asset did not immediately respond to requests for comment or were unable to &hellip;<\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/\"> <span class=\"screen-reader-text\">Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million.<\/span> Read More &raquo;<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":""},"categories":[7,6,9],"tags":[33,19,32],"class_list":["post-472","post","type-post","status-publish","format-standard","hentry","category-china","category-news","category-rd","tag-abogen","tag-mrna","tag-vaccine"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million. - Nucleic acid Building Block<\/title>\n<meta name=\"description\" content=\"Nucleic acid Building Block Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million. - Nucleic acid Building Block\" \/>\n<meta property=\"og:description\" content=\"Nucleic acid Building Block Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/\" \/>\n<meta property=\"og:site_name\" content=\"Nucleic acid Building Block\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-31T02:23:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-31T02:23:08+00:00\" \/>\n<meta name=\"author\" content=\"Nugene\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AndyLu_Pharma\" \/>\n<meta name=\"twitter:site\" content=\"@AndyLu_Pharma\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nugene\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/\"},\"author\":{\"name\":\"Nugene\",\"@id\":\"http:\/\/nugene.com.cn\/en\/#\/schema\/person\/9c38cfb28c26135316aa34152190c0d3\"},\"headline\":\"Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million.\",\"datePublished\":\"2021-12-31T02:23:07+00:00\",\"dateModified\":\"2021-12-31T02:23:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/\"},\"wordCount\":142,\"publisher\":{\"@id\":\"http:\/\/nugene.com.cn\/en\/#organization\"},\"keywords\":[\"Abogen\",\"mRNA\",\"Vaccine\"],\"articleSection\":[\"China\",\"News\",\"R&amp;D\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/\",\"url\":\"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/\",\"name\":\"Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million. - Nucleic acid Building Block\",\"isPartOf\":{\"@id\":\"http:\/\/nugene.com.cn\/en\/#website\"},\"datePublished\":\"2021-12-31T02:23:07+00:00\",\"dateModified\":\"2021-12-31T02:23:08+00:00\",\"description\":\"Nucleic acid Building Block Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million.\",\"breadcrumb\":{\"@id\":\"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9875\",\"item\":\"http:\/\/nugene.com.cn\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million.\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/nugene.com.cn\/en\/#website\",\"url\":\"http:\/\/nugene.com.cn\/en\/\",\"name\":\"Nucleic acid Building Block\",\"description\":\"service@nugene.com.cn; Hangzhou, China\",\"publisher\":{\"@id\":\"http:\/\/nugene.com.cn\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/nugene.com.cn\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"http:\/\/nugene.com.cn\/en\/#organization\",\"name\":\"Nugene Biopharm Science\",\"url\":\"http:\/\/nugene.com.cn\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/nugene.com.cn\/en\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/nugene.com.cn\/en\/wp-content\/uploads\/2021\/08\/logo-2.png\",\"contentUrl\":\"http:\/\/nugene.com.cn\/en\/wp-content\/uploads\/2021\/08\/logo-2.png\",\"width\":180,\"height\":60,\"caption\":\"Nugene Biopharm Science\"},\"image\":{\"@id\":\"http:\/\/nugene.com.cn\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/twitter.com\/AndyLu_Pharma\",\"https:\/\/www.linkedin.com\/company\/nugene\/?viewAsMember=true\"]},{\"@type\":\"Person\",\"@id\":\"http:\/\/nugene.com.cn\/en\/#\/schema\/person\/9c38cfb28c26135316aa34152190c0d3\",\"name\":\"Nugene\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/nugene.com.cn\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/77e83bf7d0179f279a53024575c03c3f0d494286cd7fa13fb5028c7a47287950?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/77e83bf7d0179f279a53024575c03c3f0d494286cd7fa13fb5028c7a47287950?s=96&d=mm&r=g\",\"caption\":\"Nugene\"},\"sameAs\":[\"http:\/\/phosphoramidite.cn\/en\"],\"url\":\"https:\/\/nugene.com.cn\/en\/index.php\/author\/dragonbio\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million. - Nucleic acid Building Block","description":"Nucleic acid Building Block Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/","og_locale":"en_US","og_type":"article","og_title":"Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million. - Nucleic acid Building Block","og_description":"Nucleic acid Building Block Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million.","og_url":"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/","og_site_name":"Nucleic acid Building Block","article_published_time":"2021-12-31T02:23:07+00:00","article_modified_time":"2021-12-31T02:23:08+00:00","author":"Nugene","twitter_card":"summary_large_image","twitter_creator":"@AndyLu_Pharma","twitter_site":"@AndyLu_Pharma","twitter_misc":{"Written by":"Nugene","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/#article","isPartOf":{"@id":"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/"},"author":{"name":"Nugene","@id":"http:\/\/nugene.com.cn\/en\/#\/schema\/person\/9c38cfb28c26135316aa34152190c0d3"},"headline":"Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million.","datePublished":"2021-12-31T02:23:07+00:00","dateModified":"2021-12-31T02:23:08+00:00","mainEntityOfPage":{"@id":"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/"},"wordCount":142,"publisher":{"@id":"http:\/\/nugene.com.cn\/en\/#organization"},"keywords":["Abogen","mRNA","Vaccine"],"articleSection":["China","News","R&amp;D"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/","url":"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/","name":"Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million. - Nucleic acid Building Block","isPartOf":{"@id":"http:\/\/nugene.com.cn\/en\/#website"},"datePublished":"2021-12-31T02:23:07+00:00","dateModified":"2021-12-31T02:23:08+00:00","description":"Nucleic acid Building Block Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million.","breadcrumb":{"@id":"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nugene.com.cn\/en\/index.php\/chinese-mrna-vaccine-research-and-development-company-suzhou-abogen-biosciences-co-ltd-is-raising-approximately-us300-million\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9875","item":"http:\/\/nugene.com.cn\/en\/"},{"@type":"ListItem","position":2,"name":"Chinese mRNA vaccine research and development company Suzhou Abogen Biosciences Co., Ltd. is raising approximately US$300 million."}]},{"@type":"WebSite","@id":"http:\/\/nugene.com.cn\/en\/#website","url":"http:\/\/nugene.com.cn\/en\/","name":"Nucleic acid Building Block","description":"service@nugene.com.cn; Hangzhou, China","publisher":{"@id":"http:\/\/nugene.com.cn\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/nugene.com.cn\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"http:\/\/nugene.com.cn\/en\/#organization","name":"Nugene Biopharm Science","url":"http:\/\/nugene.com.cn\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/nugene.com.cn\/en\/#\/schema\/logo\/image\/","url":"http:\/\/nugene.com.cn\/en\/wp-content\/uploads\/2021\/08\/logo-2.png","contentUrl":"http:\/\/nugene.com.cn\/en\/wp-content\/uploads\/2021\/08\/logo-2.png","width":180,"height":60,"caption":"Nugene Biopharm Science"},"image":{"@id":"http:\/\/nugene.com.cn\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/twitter.com\/AndyLu_Pharma","https:\/\/www.linkedin.com\/company\/nugene\/?viewAsMember=true"]},{"@type":"Person","@id":"http:\/\/nugene.com.cn\/en\/#\/schema\/person\/9c38cfb28c26135316aa34152190c0d3","name":"Nugene","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/nugene.com.cn\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/77e83bf7d0179f279a53024575c03c3f0d494286cd7fa13fb5028c7a47287950?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/77e83bf7d0179f279a53024575c03c3f0d494286cd7fa13fb5028c7a47287950?s=96&d=mm&r=g","caption":"Nugene"},"sameAs":["http:\/\/phosphoramidite.cn\/en"],"url":"https:\/\/nugene.com.cn\/en\/index.php\/author\/dragonbio\/"}]}},"_links":{"self":[{"href":"https:\/\/nugene.com.cn\/en\/index.php\/wp-json\/wp\/v2\/posts\/472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nugene.com.cn\/en\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nugene.com.cn\/en\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nugene.com.cn\/en\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nugene.com.cn\/en\/index.php\/wp-json\/wp\/v2\/comments?post=472"}],"version-history":[{"count":1,"href":"https:\/\/nugene.com.cn\/en\/index.php\/wp-json\/wp\/v2\/posts\/472\/revisions"}],"predecessor-version":[{"id":473,"href":"https:\/\/nugene.com.cn\/en\/index.php\/wp-json\/wp\/v2\/posts\/472\/revisions\/473"}],"wp:attachment":[{"href":"https:\/\/nugene.com.cn\/en\/index.php\/wp-json\/wp\/v2\/media?parent=472"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nugene.com.cn\/en\/index.php\/wp-json\/wp\/v2\/categories?post=472"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nugene.com.cn\/en\/index.php\/wp-json\/wp\/v2\/tags?post=472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}